Business Context and Reporting Period
This Form 8-K was filed by WiSA Technologies, Inc. (Note: The request metadata listed "Datavault AI Inc.", but the filing text identifies the registrant as WiSA Technologies, Inc.) on March 26, 2024. The report details a material definitive agreement entered into on the same date regarding a registered direct offering and a concurrent private placement. The offerings closed on March 27, 2024.
Key Financial Metrics and Transaction Details
- Gross Proceeds: Approximately $2.3 million.
- Securities Issued:
- Common Stock: 62,675,000 shares.
- Pre-Funded Warrants: To purchase up to 14,001,478 shares at an exercise price of $0.0001 per share.
- Private Placement Warrants: To purchase up to 76,676,478 shares at an exercise price of $0.04 per share.
- Transaction Costs:
- Placement Agent Fee: 8.0% of gross proceeds.
- Expense Reimbursement: $50,000 paid to the Placement Agent (Maxim Group LLC).
- Liquidity and Debt: The filing does not provide specific data on existing debt, cash flow, or liquidity positions outside of the proceeds from this transaction.
Material Changes and Agreements
The primary material change is the entry into a Securities Purchase Agreement and a Placement Agency Agreement. Key terms include:
- Stockholder Approval Requirement: The Private Placement Warrants are not exercisable until stockholder approval is obtained. The Company must hold a stockholder meeting on or before May 14, 2024.
- Lock-Up Period: The Company agreed not to issue or sell additional common stock or convertible securities for 30 days after the Stockholder Approval Date, unless required to satisfy Nasdaq listing requirements.
- Registration Rights: The Company must file a registration statement (Form S-1) within 45 days for the resale of Warrant Shares and use commercially reasonable efforts to have it effective within 90 days of closing.
- Termination of Prior Rights: A pre-existing Waiver Agreement regarding participation rights (dated September 1, 2023) was terminated and replaced with new rights allowing purchasers to participate in future financings (up to 90% for non-public offerings before Sept 1, 2024, and 40% for other financings) for 24 months.
Outlook, Risks, and Contingencies
- Regulatory Risk: The exercisability of the Private Placement Warrants is contingent upon obtaining stockholder approval required by Nasdaq rules.
- Anti-Dilution Provision: If a reverse stock split occurs and the volume-weighted average price falls below the warrant exercise price, the exercise price may be reduced once to the lowest daily volume-weighted average price during the specified period.
- Cashless Exercise: Warrants may be exercised on a cashless basis, potentially resulting in the issuance of fewer shares (80% of the theoretical cash exercise amount) under an "alternative cashless exercise" provision.
- Listing Requirements: The lock-up on future issuances contains an exception if the Company must complete a financing to satisfy Nasdaq's continued listing requirements, indicating potential ongoing capital needs.
Investor Verification Checklist
- Verify the exact net proceeds after deducting the 8.0% placement fee and $50,000 expense reimbursement.
- Confirm the date and outcome of the stockholder meeting scheduled for or before May 14, 2024, to determine when warrants become exercisable.
- Review the Company's current cash position to assess if the $2.3 million proceeds are sufficient to meet operational needs until the next potential financing.
- Monitor the filing of the Form S-1 registration statement for the Warrant Shares within the required 45-day window.
- Check for any announcements regarding a reverse stock split, which could trigger the warrant exercise price reduction mechanism.